Asthma and lower airway diseaseBiological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease
Key words
Abbreviations used
Cited by (0)
This study was supported by the Medical Research Council (G0601368), AstraZeneca, MedImmune, and Wellcome Trust Senior Fellowship (WT082265 to C.E.B.). The research was performed in laboratories funded in part by the European Regional Development Fund (grant no. ERDF 05567). This study was also supported in part by the National Institute for Health Research (NIHR) Leicester Respiratory Biomedical Research Unit, UK, and AirPROM (FP7-270194). The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health.
Disclosure of potential conflict of interest: M. Bafadhe has received research support from the Medical Research Council and has received travel support (for meeting expenses) from Almirall, Boehringer Ingelheim (BI), and GlaxoSmithKline (GSK). D. Desai has received travel support from BI and Chiesi. S. E. Cohen, P. Newbold, L. Rapley, J. Woods, and R. D. May are employed by and have stock/stock options in MedImmune. P. Rugman is employed by and has stock/stock options in AstraZeneca (AZ). I. D. Pavord reports payments for the recruitment of patients from UHL and personal fees from GSK, AZ, BI, Aerocrine, Boston Scientific, and Novartis. P. R. Burton has received research support from the University of Leicester. C. E. Brightling has received research support and consultancy fees from GSK, MedImmune, BI, Novartis, Roche, and Chiesi; has received travel support from BI, the American Thoracic Society, and Chiesi; and has received travel support from BI, the European Respiratory Society, and the American Thoracic Society. The rest of the authors declare that they have no relevant conflicts of interest.
- ∗
These authors contributed equally to this work.
- ‡
Joint senior authors.